Nexium Capsules RE Maintenance Specific Clinical Experience Investigation

AstraZeneca

Status: Completed

Conditions: Relapsing Reflux Esophagitis; Repeatedly Recurring Esophagitis

Study type: Observational

Funder types: Industry

Identifiers

NCT01562639

D961HC00013

Details and patient eligibility

About

The purpose of this study is to collect following data in patients given Nexium capsule (Nexium) in usual post-marketing use as the maintenance therapy for repeatedly recurring/relapsing reflux oesophagitis.

Full description

Nexium capsules Specific Clinical Experience Investigation for Maintenance Therapy for Repeatedly Recurring/Relapsing Reflux Oesophagitis

Enrollment: 647 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients with repeatedly recurring/relapsing reflux oesophagitis who will be given Nexium for the first time as a maintenance therapy.

Exclusion criteria

• Patients having reflux oesophagitis when Nexium is started (Grade A, Grade B, Grade C or Grade D of Los Angeles Classification (Hoshihara's modification) on endoscopy)
• Patients having previous history of maintenance therapy for repeatedly recurring/ relapsing reflux oesophagitis

Trial design

647 participants in 1 patient group

Nexium